AstraZeneca US Health Equity Advisory Council

As a science-led biopharmaceutical business, we recognize that systemic barriers prevent millions of Americans from accessing the right treatment at the right time to achieve the best possible health outcomes. We are committed to identifying solutions around this issue through community partnerships and new external relationships to help us positively impact underserved populations.

The AstraZeneca Health Equity Advisory Council (HEAC), formed in April 2021, serves an important role in helping to advance health equity both within AstraZeneca and via its associated practices and investments.

The HEAC is composed of a distinguished group of external community leaders, academics, healthcare professionals and nonprofit executives who possess an exceptional level of expertise pertaining to advancing health equity and eliminating disparities in care.